BW 1370U87
Alternative Names: 1370U; BW-1370U87Latest Information Update: 02 Jul 2023
At a glance
- Originator GlaxoSmithKline
- Developer GSK; Krenitsky Pharmaceuticals
- Class Antidepressants; Small molecules
- Mechanism of Action Monoamine oxidase A inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Anxiety disorders; Major depressive disorder
Most Recent Events
- 20 Sep 2000 No-Development-Reported for Anxiety disorders in USA (Unknown route)
- 19 Jun 1997 Krenitsky Pharmaceuticals is developing BW 1370U87 for Anxiety Disorders
- 19 Jun 1997 Phase-I clinical trials for Anxiety disorders in USA (Unknown route)